Bonotiode 250mcg/ml Solution for Injection
Marketer
LG Lifesciences
Salt Composition
Teriparatide (250mcg/ml)
Overview Bonotiode 250mcg/ml Solution for Injection
Parathyroid hormone analog, Teraptide 250mcg/ml Injectable Solution, is indicated for treating severe osteoporosis and high fracture risk in men and postmenopausal women. Its mechanism involves stimulating bone growth, thereby increasing bone mineral density and reducing vertebral fracture probability. Teraptide 250mcg/ml is administered subcutaneously or by a medical professional. Consistent daily dosing maximizes therapeutic efficacy; treatment typically lasts up to two years, though the physician's guidance should be followed to completion regardless of symptom improvement. Refrigerate between 2°C and 8°C. Common adverse effects include arthralgia, injection site inflammation (pain, edema, erythema), and lower extremity spasms. Report persistent or bothersome side effects to your doctor. Prior to commencing therapy, inform your physician of any pre-existing renal calculi or renal dysfunction, as hypercalcemia or hypercalciuria may occur. Pregnant or lactating individuals should seek medical counsel before use. Treatment progress may be monitored via bone densitometry as directed by your doctor.
Primary Ingredients of Bonotiode 250mcg/ml Solution for Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Bonotiode 250mcg/ml Solution for Injection
Brittle bone disease
Major Benefits of Bonotiode 250mcg/ml Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Bonotiode 250mcg/ml Solution for Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Bonotiode 250mcg/ml Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Bonotiode 250mcg/ml Solution for Injection works:
Parathyroid hormone (PTH) analog, Bonotiode 250 mcg/ml Injectable Solution, stimulates osteoblast activity and proliferation, resulting in enhanced bone density and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcoholic beverages with Bonotiode 250mcg/ml Injectable Solution. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Bonotiode 250mcg/ml Injection Solution during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bonotiode 250mcg/ml injectable solution with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Injection of Bonotiode 250mcg/ml may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Caution is advised when administering Bonotiode 250mcg/ml Injection to individuals with impaired renal function. Dosage modification of Bonotiode 250mcg/ml Injection may be necessary. Physician consultation is recommended. Bonotiode 250mcg/ml Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Bonotiode 250mcg/ml injectable solution to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Bonotiode 250mcg/ml Solution for Injection :
Should you forget a dose of Bonotiode 250mcg/ml Injectable Solution, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bonotiode 250mcg/ml Solution for Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-related Drugs |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
3,018 People bought this recently